Abstract OT3-08-01: A Phase 1 Trial of LOXO-783, a Potent, Highly Mutant-Selective, Brain-Penetrant Allosteric PI3Kα H1047R Inhibitor in PIK3CA H1047R-mutant Advanced Breast Cancer (abc) and Other Solid Tumors (PIKASSO-01, Trial in Progress)
Cancer research（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要